Status:

COMPLETED

Screening for Familial Colorectal Cancer (CRC) Patients

Lead Sponsor:

M.D. Anderson Cancer Center

Conditions:

Colorectal Cancer

Eligibility:

All Genders

Up to 60 years

Brief Summary

The goal of this psychosocial research study is to learn about the knowledge, beliefs, and attitudes that people have toward screening for colorectal cancer. Another goal is to study how families comm...

Detailed Description

You will be interviewed by a member of the study staff over the telephone. You will be asked about your awareness of screening tests for colorectal cancer, and your attitudes toward colorectal cancer ...

Eligibility Criteria

Inclusion

  • Colorectal cancer (CRC) Patients: CRC patients will be eligible if they:
  • have a diagnosis of colorectal adenocarcinoma at or before age 60, and were diagnosed between 6 and 12 months prior to being contacted about this study (to allow adequate time for dissemination of CRC risk to family members, and to avoid interference with care surrounding the initial diagnosis);
  • have at least one living FDR age 40 years or older;
  • can read and speak English.
  • FDRs of CRC Patients: FDRs will be eligible if they
  • are age 40 years or older;
  • can read and speak English.

Exclusion

  • CRC Patients: CRC patients will be excluded if they:
  • have a history of a known hereditary CRC syndrome (e.g., HNPCC, familial polyposis) or inflammatory bowel disease (e.g., ulcerative colitis or Crohn's disease); or
  • have an ECOG PS\>1.
  • FDRs of CRC patients: FDRs will be excluded if they:
  • have a history of a known hereditary CRC syndrome (e.g., HNPCC, familial polyposis) or inflammatory bowel disease (e.g., ulcerative colitis or Crohn's disease); or
  • have a personal history of colon polyps or of cancer diagnosed within 5 years prior to entry into the study, with the exception of nonmelanoma skin cancer.

Key Trial Info

Start Date :

January 29 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 12 2020

Estimated Enrollment :

269 Patients enrolled

Trial Details

Trial ID

NCT00632515

Start Date

January 29 2008

End Date

June 12 2020

Last Update

June 16 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Texas MD Anderson Cancer Center

Houston, Texas, United States, 77030